zepbound tirzepatide eli lilly sues companies selling alternative versions of its weight loss drug Eli Lilly says weight-loss drug
Description
GLP-1s, produced in the gut, regulate blood sugar, appetite, and weight
The next leap forward in healthcare will emerge from the integration of scientific discovery with the systems designed to make it accessible, safe, and enduring
Professor Giles Yeo joins this Journal Club session to discuss a recently published clinical trial paper exploring the effects of the weight loss drug, semaglutide.
Recent Findings GLP-1 agonists may be associated with breast changes and symptoms that warrant further breast imaging, including supplemental screening and/or for problem solving in the appropriate clinical scenario
Expert guidance on safe GLP-1 receptor agonist use for type 2 diabetes in the UK.
